gallstone patients undergoing oral ursodeoxycholic acid therapy had significantly higher post-prandial serum levels ( 21.5 +/- sd 14.0 mumol/l , n = 15 ) by radioimmunoassay .
C0008350
gallstone
C0042105
ursodeoxycholic acid